Genotoxicity of the some selective estrogen receptor modulators: a review

Creative Commons License

YILMAZ S., GÖNENÇ İ. M., Yilmaz E.

CYTOTECHNOLOGY, cilt.66, sa.4, ss.533-541, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 66 Sayı: 4
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1007/s10616-014-9710-7
  • Dergi Adı: CYTOTECHNOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.533-541
  • Anahtar Kelimeler: Genotoxicity, Clomiphene, Tamoxifen, Toremifene, Raloxifene, Review, DNA ADDUCT-FORMATION, BREAST-CANCER PATIENTS, CLOMIPHENE CITRATE, IN-VIVO, HUMAN LIVER, ENDOMETRIAL CARCINOMA, HEPATIC ANEUPLOIDY, TAMOXIFEN CITRATE, UTERINE-CANCER, RAT
  • Ankara Üniversitesi Adresli: Evet

Özet

The objective of this article is to review genotoxicological profile of the major selective estrogen receptor modulators, including clomiphene, tamoxifen, toremifene, raloxifene. These drugs have been used for infertility treatment and breast cancer prevention in high risk-women. However, some studies reported that especially tamoxifen is a genotoxic agent and is related with endometrial cancer. Our review indicate that clomiphene and tamoxifen were found as genotoxic agent in majority of the tests. However published reports showed that toremifene is a weakly genotoxic agent. The genotoxic effects of raloxifene are still poorly known. Further genotoxicity studies should be conducted especially for raloxifene.